InsiderTrades.com logo

ARWR Insider Trading

Insider Ownership Percentage: 3.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $39,362,097.43

Arrowhead Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Arrowhead Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arrowhead Pharmaceuticals Share Price & Price History

Current Price: $70.99
Price Change: ▼ Price Decrease of -1.154 (-1.60%)
As of 02/4/2026 10:35 AM ET

This chart shows the closing price history over time for ARWR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Arrowhead Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2026James C. HamiltonInsiderSell40,164$63.11$2,534,750.04171,958View SEC Filing Icon  
1/5/2026Patrick C. O'BrienCOOSell49,493$63.11$3,123,503.23474,908View SEC Filing Icon  
1/2/2026Christopher Richard AnzaloneCEOSell13,187$66.10$871,660.703,792,739View SEC Filing Icon  
12/29/2025Christopher Richard AnzaloneCEOSell51,726$69.13$3,575,818.383,805,926View SEC Filing Icon  
12/26/2025Mauro FerrariDirectorSell7,530$70.00$527,100.0069,053View SEC Filing Icon  
12/22/2025Christopher Richard AnzaloneCEOSell12,586$68.44$861,385.843,805,926View SEC Filing Icon  
12/19/2025Adeoye Y. OlukotunDirectorSell10,000$67.66$676,600.0033,600View SEC Filing Icon  
12/19/2025Christopher Richard AnzaloneCEOSell13,445$67.66$909,688.703,818,512View SEC Filing Icon  
12/19/2025Victoria VakienerDirectorSell10,040$67.68$679,507.2035,723View SEC Filing Icon  
12/19/2025William D. WaddillDirectorSell8,367$67.65$566,027.5556,563View SEC Filing Icon  
12/17/2025Christopher Richard AnzaloneCEOSell85,000$64.04$5,443,400.003,831,957View SEC Filing Icon  
12/16/2025Christopher Richard AnzaloneCEOSell54,298$62.58$3,397,968.843,916,957View SEC Filing Icon  
12/15/2025Christopher Richard AnzaloneCEOSell130,000$68.85$8,950,500.003,971,255View SEC Filing Icon  
12/5/2025Michael S PerryDirectorSell16,250$61.03$991,737.50115,240View SEC Filing Icon  
11/28/2025Mauro FerrariDirectorSell8,750$56.39$493,412.5068,764View SEC Filing Icon  
10/1/2025James C. HamiltonInsiderSell20,000$35.00$700,000.00212,122View SEC Filing Icon  
9/12/2025James C. HamiltonInsiderSell15,000$30.00$450,000.00232,122View SEC Filing Icon  
9/2/2025James C. HamiltonInsiderSell15,000$25.00$375,000.00247,122View SEC Filing Icon  
8/15/2025James C. HamiltonInsiderSell9,389$20.00$187,780.00262,122View SEC Filing Icon  
8/13/2025James C. HamiltonInsiderSell611$20.00$12,220.00271,511View SEC Filing Icon  
4/11/2025Christopher Richard AnzaloneCEOSell50,800$11.49$583,692.003,921,255View SEC Filing Icon  
4/9/2025Christopher Richard AnzaloneCEOSell40,322$10.07$406,042.544,022,055View SEC Filing Icon  
3/13/2025Christopher Richard AnzaloneCEOSell51,425$15.07$774,974.754,062,377View SEC Filing Icon  
3/4/2025Christopher Richard AnzaloneCEOSell133,333$17.02$2,269,327.663,773,802View SEC Filing Icon  
1/23/2025Adeoye Y. OlukotunDirectorSell959$21.00$20,139.0035,781View SEC Filing Icon  
1/6/2025James C. HamiltonInsiderSell32,729$19.82$648,688.78272,122View SEC Filing Icon  
1/6/2025Kenneth Allen MyszkowskiCFOSell27,167$19.83$538,721.61473,433View SEC Filing Icon  
1/6/2025Patrick C. O'BrienCOOSell29,184$19.82$578,426.88535,201View SEC Filing Icon  
1/2/2025Christopher Richard AnzaloneCEOSell11,520$19.05$219,456.003,764,252View SEC Filing Icon  
12/27/2024Adeoye Y. OlukotunDirectorSell2,850$20.00$57,000.0036,740View SEC Filing Icon  
12/23/2024Christopher Richard AnzaloneCEOSell12,563$19.59$246,109.173,775,772View SEC Filing Icon  
12/18/2024Christopher Richard AnzaloneCEOSell26,712$21.24$567,362.883,688,335View SEC Filing Icon  
12/16/2024William D. WaddillDirectorSell3,748$21.90$82,081.2044,125View SEC Filing Icon  
7/2/2024Tracie OliverInsiderSell9,394$25.28$237,480.32127,107View SEC Filing Icon  
5/2/2024Victoria VakienerDirectorSell1,799$23.31$41,934.6930,205View SEC Filing Icon  
3/20/2024Hongbo LuDirectorBuy1,000$27.50$27,500.0033,680View SEC Filing Icon  
3/18/2024Hongbo LuDirectorBuy1,000$27.49$27,490.0031,680View SEC Filing Icon  
3/6/2024Kenneth Allen MyszkowskiCFOSell40,000$35.19$1,407,600.00400,600View SEC Filing Icon  
1/31/2024Christopher Richard AnzaloneCEOSell57,499$32.35$1,860,092.653,715,048View SEC Filing Icon  
1/12/2024James C. HamiltonInsiderSell7,940$36.89$292,906.60210,851View SEC Filing Icon  
1/11/2024Douglas B GivenDirectorSell2,911$38.06$110,792.66129,711View SEC Filing Icon  
1/5/2024James C. HamiltonInsiderSell32,143$35.18$1,130,790.74218,791View SEC Filing Icon  
1/5/2024Kenneth Allen MyszkowskiCFOSell16,104$35.27$567,988.08440,600View SEC Filing Icon  
1/5/2024Patrick C. O'BrienCOOSell22,841$35.27$805,602.07464,385View SEC Filing Icon  
1/3/2024James C. HamiltonInsiderSell6,300$32.19$202,797.00175,934View SEC Filing Icon  
1/3/2024Patrick C. O'BrienCOOSell8,749$32.28$282,417.72403,826View SEC Filing Icon  
1/2/2024Christopher Richard AnzaloneCEOSell9,952$31.01$308,611.523,715,048View SEC Filing Icon  
12/20/2023Christopher Richard AnzaloneCEOSell12,000$28.54$342,480.003,725,000View SEC Filing Icon  
11/20/2023Javier San MartinInsiderSell19,700$28.80$567,360.00131,800View SEC Filing Icon  
10/25/2023Christopher Richard AnzaloneCEOSell24,338$24.21$589,222.983,737,000View SEC Filing Icon  
9/28/2023Victoria VakienerDirectorSell1,550$26.33$40,811.5021,734View SEC Filing Icon  
9/18/2023Christopher Richard AnzaloneCEOSell57,755$28.12$1,624,070.603,761,338View SEC Filing Icon  
7/3/2023Tracie OliverInsiderSell8,925$35.31$315,141.7561,575View SEC Filing Icon  
6/30/2023James C. HamiltonInsiderSell3,000$35.53$106,590.00188,484View SEC Filing Icon  
6/27/2023Kenneth Allen MyszkowskiCFOSell15,000$36.20$543,000.00381,704View SEC Filing Icon  
5/5/2023Douglas B GivenDirectorSell6,500$40.90$265,850.00117,635View SEC Filing Icon  
5/3/2023Christopher Richard AnzaloneCEOSell54,928$39.14$2,149,881.923,761,338View SEC Filing Icon  
3/3/2023Adeoye Y. OlukotunDirectorSell11,350$32.65$370,577.507,867View SEC Filing Icon  
2/27/2023Douglas B GivenDirectorSell875$32.62$28,542.5013,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Arrowhead Pharmaceuticals (NASDAQ:ARWR)

62.61% of Arrowhead Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ARWR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Arrowhead Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/3/2026Washington Trust Advisors Inc.545$36K0.0%-33.5%0.000%Search for SEC Filing on Google Icon
2/3/2026Crossmark Global Holdings Inc.8,348$0.55M0.0%+13.7%0.006%Search for SEC Filing on Google Icon
2/3/2026Costello Asset Management INC400$27K0.0%-57.4%0.000%Search for SEC Filing on Google Icon
2/3/2026GRIMES & Co WEALTH MANAGEMENT LLC4,440$0.30M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/3/2026Sequoia Financial Advisors LLC3,638$0.24M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/3/2026Morton Capital Management LLC CA3,726$0.25M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/3/2026Praxis Investment Management Inc.4,483$0.30M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/3/2026Mitsubishi UFJ Asset Management Co. Ltd.6,155$0.42M0.0%-58.2%0.004%Search for SEC Filing on Google Icon
2/3/2026Privium Fund Management B.V.398,204$26.44M4.9%-16.0%0.284%Search for SEC Filing on Google Icon
2/2/2026Highland Capital Management LLC3,453$0.23M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/2/2026Principal Financial Group Inc.715,539$47.51M0.0%-8.3%0.511%Search for SEC Filing on Google Icon
2/2/2026Truist Financial Corp6,307$0.42M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/2/2026Cypress Point Wealth Management LLC11,200$0.74M0.2%N/A0.008%Search for SEC Filing on Google Icon
2/2/2026Strs Ohio31,500$2.09M0.0%+205.8%0.022%Search for SEC Filing on Google Icon
2/2/2026Kornitzer Capital Management Inc. KS35,780$2.38M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/2/2026Horizon Investments LLC10,698$0.71M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/2/2026Danske Bank A S900$60K0.0%N/A0.001%Search for SEC Filing on Google Icon
1/30/2026Citizens Financial Group Inc. RI3,279$0.22M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/30/2026New York State Teachers Retirement System149,776$9.94M0.0%+0.9%0.107%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D42,471$2.82M0.0%N/A0.030%Search for SEC Filing on Google Icon
1/30/2026Sage Rhino Capital LLC5,236$0.35M0.1%N/A0.004%Search for SEC Filing on Google Icon
1/30/2026FengHe Fund Management Pte. Ltd.266,700$17.71M1.0%N/A0.190%Search for SEC Filing on Google Icon
1/30/2026M&T Bank Corp8,216$0.55M0.0%-8.9%0.006%Search for SEC Filing on Google Icon
1/29/2026Comerica Bank31,183$2.07M0.0%-20.0%0.023%Search for SEC Filing on Google Icon
1/29/2026Pictet Asset Management Holding SA1,028,736$68.64M0.1%+253.5%0.757%Search for SEC Filing on Google Icon
1/29/2026UBS Group AG987,287$65.55M0.0%+7.5%0.727%Search for SEC Filing on Google Icon
1/29/2026Sanctuary Advisors LLC27,347$1.82M0.0%N/A0.020%Search for SEC Filing on Google Icon
1/29/2026Teachers Retirement System of The State of Kentucky34,787$2.31M0.0%+5.6%0.026%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.15,293,121$1.02B0.0%-4.6%11.255%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.30,130$2M0.2%-28.7%0.022%Search for SEC Filing on Google Icon
1/28/2026Arizona State Retirement System34,883$2.32M0.0%+6.8%0.026%Search for SEC Filing on Google Icon
1/28/2026WPG Advisers LLC543$36K0.0%+384.8%0.000%Search for SEC Filing on Google Icon
1/28/2026B. Metzler seel. Sohn & Co. AG20,695$1.37M0.0%N/A0.015%Search for SEC Filing on Google Icon
1/28/2026M&T Bank Corp240,634$15.98M0.0%+2,569.6%0.177%Search for SEC Filing on Google Icon
1/28/2026Universal Beteiligungs und Servicegesellschaft mbH159,538$10.59M0.0%-0.9%0.117%Search for SEC Filing on Google Icon
1/27/2026Evergreen Capital Management LLC6,229$0.41M0.0%N/A0.005%Search for SEC Filing on Google Icon
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank 39,365$2.61M0.0%+7.0%0.029%Search for SEC Filing on Google Icon
1/27/2026First Horizon Corp480$32K0.0%N/A0.000%Search for SEC Filing on Google Icon
1/27/2026GF Fund Management CO. LTD.2,668$0.18M0.0%-10.3%0.002%Search for SEC Filing on Google Icon
1/26/2026Merit Financial Group LLC6,303$0.42M0.0%N/A0.005%Search for SEC Filing on Google Icon
1/26/2026Mirae Asset Global Investments Co. Ltd.6,599$0.44M0.0%+23.5%0.005%Search for SEC Filing on Google Icon
1/26/2026PDS Planning Inc3,091$0.21M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/26/2026CWM LLC12,347$0.82M0.0%+1.4%0.009%Search for SEC Filing on Google Icon
1/26/2026Wealth Effects LLC143,300$9.51M3.0%-14.9%0.105%Search for SEC Filing on Google Icon
1/23/2026Farther Finance Advisors LLC11,941$0.79M0.0%+2,923.0%0.009%Search for SEC Filing on Google Icon
1/23/2026Oak Ridge Investments LLC30,687$2.04M0.1%-2.7%0.023%Search for SEC Filing on Google Icon
1/23/2026Financial Enhancement Group LLC5,525$0.37M0.0%N/A0.004%Search for SEC Filing on Google Icon
1/23/2026State of Alaska Department of Revenue70,399$4.67M0.0%+1.2%0.052%Search for SEC Filing on Google Icon
1/23/2026Choreo LLC6,688$0.45M0.0%N/A0.005%Search for SEC Filing on Google Icon
1/23/2026Ritholtz Wealth Management3,948$0.26M0.0%N/A0.003%Search for SEC Filing on Google Icon
1/21/2026Yousif Capital Management LLC38,125$2.49M0.0%-12.5%0.028%Search for SEC Filing on Google Icon
1/21/2026Sound Income Strategies LLC393$25K0.0%-51.2%0.000%Search for SEC Filing on Google Icon
1/16/2026Aberdeen Group plc286,146$19M0.0%-45.0%0.211%Search for SEC Filing on Google Icon
1/16/2026Vanguard Capital Wealth Advisors9,444$0.63M0.5%-16.3%0.007%Search for SEC Filing on Google Icon
1/16/2026Tema Etfs LLC11,542$0.77M0.1%-63.7%0.008%Search for SEC Filing on Google Icon
1/15/2026Nisa Investment Advisors LLC4,640$0.31M0.0%+44.0%0.003%Search for SEC Filing on Google Icon
1/15/2026Moody Lynn & Lieberson LLC22,000$1.46M0.1%+63.0%0.016%Search for SEC Filing on Google Icon
1/15/2026Allspring Global Investments Holdings LLC7,277$0.49M0.0%N/A0.005%Search for SEC Filing on Google Icon
1/14/2026Vantage Wealth3,750$0.25M0.1%N/A0.003%Search for SEC Filing on Google Icon
1/14/2026Exchange Traded Concepts LLC17,298$1.15M0.0%-44.1%0.013%Search for SEC Filing on Google Icon
1/14/2026Pallas Capital Advisors LLC5,699$0.38M0.0%N/A0.004%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC50,299$3.34M0.0%+11.6%0.037%Search for SEC Filing on Google Icon
1/9/2026Assenagon Asset Management S.A.684,889$45.47M0.1%+79.9%0.504%Search for SEC Filing on Google Icon
1/8/2026Wealth Enhancement Advisory Services LLC18,961$1.34M0.0%+25.7%0.014%Search for SEC Filing on Google Icon
1/8/2026Fermata Advisors LLC6,000$0.40M0.1%N/A0.004%Search for SEC Filing on Google Icon
1/8/2026Nordea Investment Management AB324,251$21.57M0.0%-12.9%0.239%Search for SEC Filing on Google Icon
1/5/2026GAMMA Investing LLC3,649$0.24M0.0%+39.0%0.003%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.775,717$26.75M0.0%+90.3%0.571%Search for SEC Filing on Google Icon
12/15/2025Hudson Bay Capital Management LP90,000$3.10M0.0%-65.4%0.066%Search for SEC Filing on Google Icon
12/2/2025IFP Advisors Inc14,593$0.54M0.0%-1.8%0.011%Search for SEC Filing on Google Icon
12/1/2025Cantor Fitzgerald L. P.19,500$0.67M0.0%+14.7%0.014%Search for SEC Filing on Google Icon
11/21/2025CIBC Bancorp USA Inc.12,860$0.44M0.0%N/A0.009%Search for SEC Filing on Google Icon
11/17/2025Keystone Financial Group8,000$0.28M0.0%N/A0.006%Search for SEC Filing on Google Icon
11/17/2025CANADA LIFE ASSURANCE Co129,958$4.39M0.0%+11.7%0.094%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP1,000,158$34.50M0.2%+34.0%0.723%Search for SEC Filing on Google Icon
11/17/2025PDT Partners LLC90,819$3.13M0.2%-40.6%0.066%Search for SEC Filing on Google Icon
11/17/2025Virtus Advisers LLC14,462$0.50M0.3%+581.5%0.010%Search for SEC Filing on Google Icon
11/17/2025Voloridge Investment Management LLC402,659$13.89M0.0%N/A0.291%Search for SEC Filing on Google Icon
11/17/2025Velan Capital Investment Management LP6,500$0.22M0.2%N/A0.005%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC33,203$1.15M0.0%+42.3%0.024%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC28,658$0.99M0.1%N/A0.021%Search for SEC Filing on Google Icon
11/17/2025Nomura Holdings Inc.39,218$1.35M0.0%-390.2%0.028%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC109,807$3.79M0.0%-35.0%0.079%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.138,020$4.76M0.0%-8.8%0.100%Search for SEC Filing on Google Icon
11/17/2025Integrated Wealth Concepts LLC6,577$0.23M0.0%N/A0.005%Search for SEC Filing on Google Icon
11/17/2025Jain Global LLC53,957$1.86M0.0%N/A0.039%Search for SEC Filing on Google Icon
11/17/2025Gotham Asset Management LLC31,863$1.10M0.0%+68.9%0.023%Search for SEC Filing on Google Icon
11/17/2025Fred Alger Management LLC306,833$10.58M0.0%N/A0.222%Search for SEC Filing on Google Icon
11/17/2025Focus Partners Wealth22,110$0.76M0.0%+24.2%0.016%Search for SEC Filing on Google Icon
11/17/2025Baker BROS. Advisors LP1,670,762$57.63M0.4%+77.9%1.208%Search for SEC Filing on Google Icon
11/17/2025Cantor Fitzgerald L. P.19,500$0.67M0.0%+14.7%0.014%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE760,687$26.24M0.0%+21.5%0.550%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC83,388$2.88M0.0%+34.6%0.060%Search for SEC Filing on Google Icon
11/17/2025Aquatic Capital Management LLC25,671$0.89M0.0%-72.7%0.019%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC81,310$2.80M0.0%-20.7%0.059%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.155,894$5.38M0.0%-2.0%0.113%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.274,163$9.46M0.0%+2.7%0.198%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC543,916$18.76M0.1%+12.8%0.393%Search for SEC Filing on Google Icon
11/14/2025Creative Planning52,006$1.79M0.0%+13.9%0.038%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.227,269$7.84M0.0%+33.9%0.164%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Arrowhead Pharmaceuticals logo
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes Plozasiran, which is in Phase 2b and one Phase 3 clinical trial to treat hypertriglyceridemia, mixed dyslipidemia, and chylomicronemia syndrome; Zodasiran that is in Phase 2b clinical trial for the treatment of dyslipidemia and hypertriglyceridemia; ARO-PNPLA3, which is in Phase 1 clinical trial to treat patients with non-alcoholic steatohepatitis; ARO-RAGE that is in Phase 1/2a clinical trial to treat inflammatory pulmonary conditions; and ARO-MUC5AC, which is in Phase 1/2a clinical trial to treat muco-obstructive pulmonary diseases. It also develops ARO-MMP7 that is in Phase 1/2a clinical trial for treatment of idiopathic pulmonary fibrosis; ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-SOD1 for the potential treatment of amyotrophic lateral sclerosis; and ARO-C3, which is in Phase 1/2a clinical trial for the treatment of patients with various complement mediated or complement associated renal diseases. In addition, the company is involved in the development of JNJ-3989, which is in Phase 2 clinical trial to treat chronic hepatitis B virus infection; Olpasiran that is in Phase 3 clinical trial to reduce the production of apolipoprotein A; GSK-4532990 that is in phase 2 clinical trial to treat liver diseases; HZN-457, which is in phase 1 clinical trial to treat uncontrolled gout; and Fazirsiran that is in Phase 3 clinical trial for the treatment for liver disease associated with alpha-1 antitrypsin deficiency. Arrowhead Pharmaceuticals, Inc. has license and research collaboration agreements with Janssen Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Horizon Therapeutics Ireland DAC; Amgen Inc.; and Glaxosmithkline Intellectual Property (No. 3) Limited. The company was founded in 2003 and is headquartered in Pasadena, California.
Read More on Arrowhead Pharmaceuticals

Today's Range

Now: $70.99
Low: $72.24
High: $72.24

50 Day Range

MA: $66.29
Low: $52.78
High: $73.00

52 Week Range

Now: $70.99
Low: $9.57
High: $76.76

Volume

1,560 shs

Average Volume

2,666,490 shs

Market Capitalization

$9.94 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Who are the company insiders with the largest holdings of Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals' top insider shareholders include:
  1. Christopher Richard Anzalone (CEO)
  2. Patrick O'brien (COO)
  3. Kenneth Allen Myszkowski (CFO)
  4. James C Hamilton (Insider)
  5. Tracie Oliver (Insider)
  6. Michael S Perry (Director)
  7. Mauro Ferrari (Director)
  8. William D Waddill (Director)
  9. Adeoye Y Olukotun (Director)
  10. Victoria Vakiener (Director)
  11. Hongbo Lu (Director)
Learn More about top insider investors at Arrowhead Pharmaceuticals.

Who are the major institutional investors of Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 11.25%
  2. Pictet Asset Management Holding SA — 0.76%
  3. UBS Group AG — 0.73%
  4. Principal Financial Group Inc. — 0.51%
  5. Assenagon Asset Management S.A. — 0.50%
  6. Privium Fund Management B.V. — 0.28%
Learn More about top institutional investors of Arrowhead Pharmaceuticals stock.

Which institutional investors are selling Arrowhead Pharmaceuticals stock?

During the last quarter, ARWR stock was sold by these institutional investors:
  1. Vanguard Group Inc.
  2. Aberdeen Group plc
  3. Privium Fund Management B.V.
  4. Principal Financial Group Inc.
  5. Nordea Investment Management AB
  6. Wealth Effects LLC
  7. Tema Etfs LLC
  8. Exchange Traded Concepts LLC
In the last year, company insiders that have sold Arrowhead Pharmaceuticals company stock include:
  1. Christopher Richard Anzalone (CEO)
  2. Patrick O'brien (COO)
  3. Kenneth Allen Myszkowski (CFO)
  4. James C Hamilton (Insider)
  5. Tracie Oliver (Insider)
  6. Michael S Perry (Director)
  7. Mauro Ferrari (Director)
  8. William D Waddill (Director)
Learn More investors selling Arrowhead Pharmaceuticals stock.

Which institutional investors are buying Arrowhead Pharmaceuticals stock?

Within the last quarter, ARWR stock was acquired by institutional investors including:
  1. Pictet Asset Management Holding SA
  2. Assenagon Asset Management S.A.
  3. FengHe Fund Management Pte. Ltd.
  4. M&T Bank Corp
  5. UBS Group AG
  6. State of New Jersey Common Pension Fund D
  7. Kornitzer Capital Management Inc. KS
  8. Sanctuary Advisors LLC